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 Abstract  
The impact of cocoa on microbiota composition, its crosstalk with the immune system and the 
SCFA production, focusing on the involvement of cocoa fibre were investigated Wistar rats were 
fed for 3-weeks a standard diet, a diet containing 10%-cocoa (C10), cocoa fibre (CF) or inulin (I). 
Faecal and serum samples were collected before and after the intervention and caecal content and 
colon sample were collected at the end. Microbiota composition and IgA-coated bacteria and the 
SCFA content was quantified. The colonic expression of immune-related genes was studied. The 
CF diet increased Bifidobacterium and Lactobacillus counts, the proportion of IgA-coated bacteria, 
the SCFA concentrations and the TLR2, TLR5, TLR7 and occludin expression. With the exception 
on Lactobacillus counts, the I diet modified the other variables in a more modest way than the CF 
diet. The CF, unlike from the C10 diet, has prebiotic effects and modulates intestinal immune 
markers. 
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 1. Introduction 
Cocoa consumption has been suggested to correlate with an amelioration of cardiovascular 
alterations such as hypertension and atherosclerosis, and with protective effects on proliferative 
disorders and neurodegenerative diseases (Ellam & Williamson, 2013). In addition, cocoa has been 
reported to modulate the immune response both at systemic and intestinal levels (Massot-Cladera et 
al. 2012; Pérez-Berezo et al. 2011; Pérez-Cano et al. 2013), but understanding of the mechanisms 
and specific components within cocoa which exert these effects is limited. Cocoa contains bioactive 
compounds such as polyphenols, mainly flavonoids: (+)-catechin and (–)-epicatechin as monomers 
and procyanidins as polymers, among others (Shahidi & Ambigaipalan, 2015), but cocoa is also a 
good source of dietary fibre (Lecumberri et al. 2007). 
Some of the polyphenols present in cocoa are able to pass intact through the small intestine, 
reaching the colon (Etxeberria et al. 2013; Monagas et al. 2010), where they are subject to 
metabolism by the intestinal microbiota. This conversion is essential for their absorption and 
generates new compounds with potentially greater biological activities than the original compounds 
(Clifford, 2004; Monagas et al. 2010; Neilson & Ferruzzi, 2011; Selma et al. 2009; Tzounis et al. 
2008). Both the dietary polyphenols and their microbially-derived phenolic metabolites modulate 
the gut microbiota composition (Etxeberria et al. 2013; Lee et al. 2006; Massot-Cladera et al. 2014; 
Selma et al. 2009; van Duynhoven et al. 2013). Therefore, there is a reciprocal relationship between 
bacteria and polyphenols: bacteria can be involved in the polyphenol metabolism, and flavonoids 
can influence microbiota growth and composition (Hayek, 2013). 
Dietary fibre (DF) present in cocoa consists of complex carbohydrates which resist hydrolysis and 
digestion in the stomach and the small intestine, and thus reach the colon intact. DF is then 
available to be metabolized to oligosaccharides by the colonic microbiota, forming short chain fatty 
acids (SCFA) during the fermentation and resulting in the production of gases (CO2, CH4 and H2) 
and heat (Jakobsdottir et al. 2013; Puertollano et al. 2014; Wong & Jenkins, 2007). Acetate, 
propioniate and butyrate (in a ratio of 3:1:1) are the main SCFAs produced, and are well known to 
possess beneficial properties for host health (Cook & Sellin, 1998; Wong et al. 2006) through their 
effects on immunoregulation, colonic gene expression, cancer, obesity, insulin resistance, metabolic 
regulation as well as maintaining gut and overall health (Fukuda et al. 2011; Gao et al. 2009; 
Maslowski & Mackay, 2011; Peng et al. 2009; Puertollano et al. 2014). SCFA, especially butyrate, 
are also used as energy sources for colonocytes (Jakobsdottir et al. 2013; Puertollano et al. 2014). 
SCFA production is liable to be modified depending, amongst others factors, on the fibre source 
 and the microbiota composition. In addition to a direct influence of fibre as a substrate for SCFA 
production, it may also exert an indirect modulatory effect on SCFA production by altering the 
composition of the gut microbiota (Claesson et al. 2012; Turnbaugh et al. 2009; Wu et al. 2011) 
primarily by means of a bifidogenic shift (Meyer & Stasse-Wolthuis, 2009). Thus, the proportion of 
different SCFA producers and, as a result, the SCFA production could be modified by fibre intake 
(Puertollano et al. 2014).  
It has recently been suggested that the phenolic fraction of cocoa could not be the main responsible 
of the health-related outcomes and may be other cocoa components such as cocoa fibre can be, or at 
least in part, responsible of such effects (Massot-Cladera et al. 2014). This is also the case for other 
complex foods, such as grapes (Touriño et al. 2009). On this basis, the aim of the current study was 
to evaluate the contribution of fibre vs phenolics in cocoa on the gut microbiota composition, the 
production of SCFA and on immune-related markers in rats. 
 
2. Material and Methods 
2.1. Animals and diets. Female Wistar rats (3-week-old, 40 animals) were obtained from Janvier 
Labs (Saint-Berthevin, France) and housed in cages under conditions of controlled temperature and 
humidity in a 12:12 light-dark cycle. The rats were randomly distributed into four dietary groups 
(n=10/each). The reference group (REF) was fed with a standard diet AIN-93M (Harlan, Barcelona, 
Spain); the cocoa group (C10) received chow with 10% cocoa providing a final proportion of 0.4% 
of polyphenols, 0.85% soluble fibre and 2.55% of insoluble fibre; the cocoa fibre group (CF) was 
fed a diet with the same soluble and insoluble fibre proportion from cocoa as C10 diet (0.85% and 
2.34%, respectively) but with a very low amount of polyphenols (<0.02%), provided by 5.22% 
cocoa fibre powder; and the reference fibre group (I) received 0.85% of soluble fibre as inulin 
(Tables 1 and 2). The diets, provided ad libitum, were fed for three weeks. Natural Forastero cocoa 
and cocoa fibre (mainly rich in cellulose, hemicellulose and pectic substances) powders (Nutrexpa 
Group S.L.Barcelona, Spain) were used to elaborate the C10 and CF diets, respectively. Inulin 
obtained from chicory roots (Fibruline® Instant; InnovaFood 2005, S.L, Barcelona, Spain) was 
used for the I diet. The three experimental diets were elaborated on basis of the AIN-93M formula 
by subtracting the amount of carbohydrates, proteins, lipids and insoluble fibre provided by the 
corresponding cocoa and cocoa fibre. The resulting chows were isoenergetic and had the same 
  
Components 
REF (g/kg) 
AIN-93M 
C10 (g/kg) CF (g/kg) I (g/kg) 
 
Casein 121.5 97.1 109.7 118.7 
L-Cystine 1.8 1.4 1.4 1.6 
Corn Starch 418.1 423.7 437.2 426.4 
Maltodextrin 148.5 118.7 120.4 131.5 
Sucrose 102.6 108.7 110.9 110.9 
Soybean oil 38.2 26.2 33.5 38.9 
Cellulose 50 24.5 26.5 50.0 
Minerals 35.3 27.7 27.9 31.3 
Vitamins 9.1 7.2 7.2 8.1 
Choline bitartrate 2.5 2.0 2.0 2.2 
tert-Butylhydroquine 0.008 0.006 0.006 0.006 
Water 72.4 63 71.1 72 
Cocoa powder - 100 -              - 
    
Cocoa fiber powder           -    - 52.3   - 
Inulin powder            -    -     -    8.5 
     
     
     
 
 
Components 
Cocoa powder 
(g/kg) 
Cocoa fiber 
powder (g/kg) 
Inulin powder 
(g/kg) 
    
Protein 22    8      - 
Carbohydrate 16    0.5      - 
Lipid 11    4.8      - 
Fiber (insoluble/soluble) 34 (25.5/8.5)  31.9 (23.4/8.5)    8.5 (- /8.5) 
Minerals 6 7      - 
Total Polyphenols
1
 4     0.02      - 
Water 7  -      -  
    
   
 
proportion of macronutrients (carbohydrates, proteins and lipids) and insoluble fibre as the standard 
diet.  
Table 1 Composition of experimental diets (g/kg diet).  Reference diet (REF); cocoa  
diet (C10); cocoa fibre diet (CF); inulin diet (I). 
 
 
 
 
 
 
 
 
 
Body weight and food intake were monitored throughout the study. Experiments were performed 
according to the Guide for the Care and Use of Laboratory Animals, and experimental procedures 
were approved by the Ethical Committee for Animal Experimentation of the University of 
Barcelona (ref. 358/12).  
Table 2 Composition of nutrients provided by the cocoa, cocoa fibre  
and inulin extracts (g/kg diet). 
 
 
 
 
 
 1 Total polyphenol compounds were quantified by Folin-Ciocalteu. 
method.  
 
 2.2. Sample collection and processing. At the beginning and end of the study, blood samples were 
collected and serum was kept at -20 ºC until SCFA analysis. Faecal samples were collected at the 
same time points and were processed for bacterial characterization and SCFA analysis. After 3 
weeks of nutritional intervention, the colon (CO) were excised and immediately immerse in 
RNAlater® (Ambion, Life Technologies, Austin, TX, USA), incubated at 4 ºC overnight and stored 
at -20 ºC until PCR analysis. At the same time point, caecum content was obtained and processed 
for SCFA analysis. Faecal and caecal homogenates were obtained following procedures previously 
described (Massot-Cladera et al. 2012) with some modifications. Faeces were weighed, diluted 
1:10 (w/v) in phosphate-buffered saline (PBS, pH 7.2) and homogenized using a Polytron 
(Kinematica, Lucerne, Switzerland). The homogenates obtained were then centrifuged (300 g, 
1 min, 4 ºC) and kept at -20 ºC until the SCFA analysis. Faecal supernatant was used for the 
bacterial characterization and IgA-coated bacteria determination as described previously (Massot-
Cladera, et al. 2012). pH of faecal samples and caecal content was determined using a surface 
electrode (Crison Instruments, S.A., Barcelona, Spain).  
2.3. Short Chain Fatty Acid analysis. Serum SCFA were measured by gas chromatography as 
previously reported with some modifications (Fernandes et al. 2011; Vogt & Pencharz, 2004). A 
200 µL aliquot of serum was filtered through a 30-kDa micropartition system (Vivaspin RC 
VS02H22 filters, Sartorius Inc., Mississauga, ON, Canada) by centrifugation (14000 g, 4 °C, 
90 min). The protein-free filtrate supernatant was mixed with 25 µL of internal standard solution 
consisting of 100 mM ethyl-butyrate and 100 mM formic acid in a 2 mL Hichrom vial (Agilent 
Technologies, South Queensferry, West Lothian, UK). One microliter of each sample was injected 
into a 5890 Series II GC system (HP, Crawley, West Sussex, UK) fitted with a NukolTM Capilllary 
Column (30 m × 0.53 mm × 1.0 μm, SUPELCOTM Analytical, Gilligham ,UK) and flame ionisation 
detector. The carrier gas, helium, was delivered at a flow rate of 14 mL/min. The head pressure was 
set at 10 psi with split injection.  Run conditions were: initial temperature 60 °C, 1 min; + 20 °C / 
min to 145 °C; + 4 °C / min to 200 °C, hold 25 min.  Peaks were integrated using Agilent 
ChemStation software (Agilent Technologies, Oxford, UK) and SCFA content quantified by single 
point internal standard method. Peak identity and internal response factors were determined using a 
1 mM calibration cocktail including acetic, propionic, iso-butyric, butyric, iso-valeric, valeric, 
ethyl-butyric and caproic acids.  
To prepare the faecal and caecal diluted samples at 1:10 (w/v) for gas chromatography, 500 µL of 
faecal and caecal homogenates were centrifuged (18000 g at room temperature for 10 min), and the 
 supernatant was filtered using a sterile Millex® syringe-driven sterile filter unit (0.22 µm; Merck 
Millipore, Eschborn, Germany) and then analyzed for SCFA determination following the same 
protocol as that used for the serum samples. From the same animal, SCFA were also determined in 
serum and faecal samples obtained before the nutritional intervention. Therefore, results from these 
samples are expressed as the difference in SCFA concentration after three weeks of nutritional 
intervention (µM). Results from caecum content are presented as final SCFA concentration (µM). 
2.4. Lactic acid determination. D-lactic acid concentration in caecal and faecal homogenates and 
serum were quantified by an ELISA kit following the manufacturer’s instructions (BioNova 
Científica, S.L., Barcelona, Spain). Absorbance was measured in a microplate photometer 
(Labsystems Multiskan, Helsinki, Finland) at 450 nm. Data were interpolated by means of Ascent 
v.2.6 software (Thermo Fisher Scientific, S.L.) into the standard curves and expressed as the mean 
± SEM (µg/mL). 
2.5. Fluorescence in situ hybridization (FISH) of gut microbiota. The bacterial groups present in 
faeces were characterized by means of FISH technique using group- or genus-specific 
fluorochrome-conjugated probes (Sigma-Aldrich, Madrid, Spain), as previously established 
(Massot-Cladera et al. 2014), with some modifications.  The specific probes and controls used in 
this study, as well as the hybridization conditions, are included as supplementary material (See 
supplementary Table S1). In order to express the results with respect to total bacteria, the samples 
were mixed with propidium iodine (PI, Sigma-Aldrich, Madrid, Spain) prior to FCM analysis 
(Massot-Cladera et al. 2012).  
2.6. Immunoglobulin-coated bacterial staining. The proportion of IgA-coated bacteria was 
determined as previously established (Massot-Cladera et al. 2012) with minor modifications. In the 
present study, faecal homogenates were diluted in 1% (v/v) FBS/PBS and centrifuged (8000 g, 
5 min, 4 ºC). 
2.7. Flow cytometry bacterial analysis. FCM analysis for bacterial characterization was performed 
using a FacsAria SORP sorter (BD, San José, CA, USA) as previously described (Massot-Cladera 
et al. 2012). Commercial Flow Check
TM
 Fluorospheres (Beckman Coulter, Inc. FL, USA) were 
used to determine total counts combined with PI. Analysis was performed using Flowjo v7.6.5 
software (Tree Star, Inc.). Microbiota composition results were expressed as the faecal positive 
cells/g of faeces in each sample. Taking into account the studied genera, the Firmicutes (F) to 
 Bacteroidetes (B) ratio (F/B ratio) for each group was also expressed. Ig-coated bacteria results 
were expressed as previously described (Massot-Cladera et al. 2012). 
2.8. Assessment of RNA gene expression by RT-PCR. The RNA was isolated from colonic tissue 
samples in RNAlater® by the RNAeasy® mini Kit (Qiagen, Madrid, Spain) following the 
manufacturer’s recommendations. The NanoDrop spectrophotometer and NanoDrop IVD-1000 
V.3.1.2 software (NanoDrop Technologies, Wilmington, DE, USA) were used to quantify the 
amount of RNA obtained. The Agilent 2100 Bioanalyzer with the RNA 6000 LabChip 1 kit 
(Agilent Technologies, Madrid, Spain) was used to assess the RNA integrity for each sample. 
Two μg of total RNA was converted to cDNA. Specific PCR TaqMan® primers and probes 
(Applied Biosystems, AB, Weiterstadt, Germany) were used to measure selected targets: tlr2 
(Rn02133647_s1, inventoried (In)), tlr4 (Rn00569848_m1, In), tlr5 (Rn04219239_s1, In), tlr7 
(Rn01771083_s1, In), tlr9 (Rn01640054_m1, In) and Ocldn (Rn00580064_m1, In). Quantitative 
real-time PCR assays were performed in duplicate for each sample using an ABI PRISM 7900HT 
Sequence Detection System (AB). Quantification of the studied genes was normalized to the 
housekeeping Gusb (Rn00566655_m1, In). The SDS v2.4 software (AB) was used to analyze the 
expression data. The amount of target mRNA relative to the endogenous control expression was 
calculated for the three nutritional intervention groups relative to values from the REF group which 
represents 100% gene expression, using the standard 2
-∆∆Ct
 method, as previously described (Pérez-
Cano et al. 2009). Results are expressed as the mean ± SEM of the percentage of these values. 
2.9. Statistical analysis. Levene’s and Kolmogorov–Smirnov tests were applied to assess variance 
equality and normal distribution, respectively. Conventional one-way ANOVA followed by the 
Bonferroni post hoc significance test was performed when the assumptions of normality and equal 
variance were met. Where this was not the case, non-parametric tests (Kruskal-Wallis and Mann–
Whitney U rank-sum test) were used to assess significance and in some cases the non-parametric 
Friedman test was used to compare three or more matched groups. The Spearman’s correlation test 
was used to calculate the correlations between bacterial count changes and either faecal or caecal 
pH, SCFAs production or Ig-coated bacteria changes as a result of the dietary intervention. 
Statistical analysis was performed using the software package SPSS 22.0 (SPSS, Inc.) and 
significant differences were established at p < 0.05. 
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3. Results 
3.1. Body weight and chow intake. Body weight and chow intake were monitored throughout the 
study (Fig. 1). Although the initial body weight was similar among the groups, a statistically slower 
body weight gain was observed in cocoa-fed animals in comparison to the other groups (p < 0.01 
day 7, 14, 21) (Fig. 1A). This effect was not related to lower chow intake, which was similar 
throughout the study among all experimental groups (Fig. 1B).  
 
Fig. 1 Body weight (A) and chow intake (g/100 g rat/day) (B) monitored throughout the nutritional 
intervention. Values are expressed as mean ± SEM (n=10). Reference diet (REF); Cocoa diet (C10); 
Cocoa fibre diet (CF); Inulin diet (I). Statistical differences: *p < 0.05 vs REF; α p < 0.05 vs C10; β 
p < 0.05 vs CF and δ p < 0.05 vs I. 
 
 
 
3.2. SCFA production. At the end of the study, for all groups, the highest concentration of SCFA 
was detected in the content of the caecum (6184.5 ± 305.2 µM), which was approximately twofold 
higher than that quantified in faecal samples (3053 ± 1451.4 µM). The lowest concentration of 
SCFA was detected in serum samples (216.9 ± 6.2 µM).  
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Fig. 2 Effects of cocoa fibre on SCFA production. Caecal SCFA concentration at the end of the 
study (A, B); and difference in faecal (C,D) and serum (E,F) SCFA concentration  compared to the 
initial values after three weeks of nutritional intervention. Values are expressed as mean ± SEM 
(n=10). Reference diet (REF); Cocoa diet (C10); Cocoa fibre diet (CF); Inulin diet (I). Statistical 
differences: *p < 0.05 vs REF; α p < 0.05 vs C10; β p < 0.05 vs CF and δ p < 0.05 vs I. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Regarding caecum SCFA content (Fig. 2A and 2B), the C10-fed animals presented higher butyric 
acid and lower iso-butyric and caproic acid concentrations than the animals fed with a standard diet 
(p = 0.028, 0.049 and 0.002, respectively). The CF diet resulted in higher concentration of the total 
caecal SCFA in comparison to the other dietary groups (p = 0.0001 vs REF, 0.012 vs C10 and 0.010 
vs I). This increase was reflected in all three SCFA: acetic (p = 0.0001 vs REF, 0.043 vs C10 and 
0.031 vs I), propionic (p = 0.045 vs REF and p = 0.010 vs C10) and butyric (p < 0.0001 vs REF and 
p = 0.006 vs C10) acids. The I diet decreased the caproic concentration compared to the REF group 
(p < 0.0001) whereas it increased the proportion of butyric acid compared to the REF (p < 0.0001) 
and C10 (p < 0.0001) diets and the concentration of propionic in comparison with the C10 diet 
(p = 0.010). All these changes were reflected in a higher concentration of total SCFA in comparison 
to the REF group (p = 0.05). Similar caecal lactic acid concentration was detected for all groups 
(1.17 ± 0.52 µg/mL).  
Concerning faecal SCFA, all groups showed a similar pattern at baseline (data not shown). 
However, after three weeks of nutritional intervention, some significant differences were observed 
among groups (Fig. 2C and 2D). Faecal SCFA were not significantly modified by the C10 diet. 
The CF diet resulted in an increase in acetic and propionic acid concentrations, which were 
significantly higher than those in the C10 group (p = 0.019 and 0.050, respectively), but did not 
differ from those observed in the REF group. These increases were reflected in the total SCFA 
proportion compared to the C10 group (p = 0.031). The diet containing inulin tended to reduce 
acetic acid and to increase butyric and propionic acids proportions with respect to their initial 
values, although these changes did not differ from the other groups. Regarding lactic acid, all 
groups showed a similar concentration in faecal samples at the baseline (5.34 ± 1.73 µg/mL) and 
also after three weeks of nutritional intervention (4.38 ± 0.96 µg/mL) without significant 
differences among them. 
There was a ~ 50 µM increase in total serum SCFA concentration in the REF group due to a rise in 
acetic acid, while the concentrations of other SCFA were reduced (Fig. 2E and 2F). The C10 diet 
resulted in a significant reduction in serum valeric acid (p = 0.0001 vs REF). The CF diet produced 
the highest increase in serum total SCFA concentration after three weeks of nutritional intervention 
(p = 0.034 vs C10) due to a higher proportion of acetic (p = 0.05 vs REF and p = 0.019 vs C10). 
Nevertheless, CF diet also decreased serum valeric acid (p < 0.0001). The inulin-fed animals 
showed an increase in serum caproic and iso-valeric acid concentrations which differed from those 
quantified in the REF and C10 groups (p = 0.002 vs REF and p = 0.007 and 0.041 vs C10, 
 0 7 14 21
F
a
ec
a
l 
p
H
4.0
4.5
5.0
5.5
6.0
6.5
7.0
*
*
*
*
*
*
*
C
a
ec
a
l 
p
H
4.0
4.5
6.8
7.2
7.6
8.0
Cecal: -- 
0 7 14 21
F
a
ec
a
l 
p
H
4.0
4.5
5.0
5.5
6.0
6.5
7.0
*
*
*
*
*
*
*
C
a
ec
a
l 
p
H
4.0
4.5
6.8
7.2
7.6
8.0
Cecal: -- 
BA
α
α
αα
δ
Diet days
ϕ
ϕ
ϕ
ϕ
REF C10 CF I
*
*
*
REF C10 CF I
respectively). In addition, I diet resulted in stronger valeric acid decrease than that produced by the 
REF (p = 0.004) and C10 diets (p = 0.05) and similar to that seen in the CF diet. Before nutritional 
intervention, acid lactic was not detected in serum from any group and three weeks later all groups 
showed a similar concentration (0.75 ± 0.17 µg/mL).  
3.3. Faecal and caecal pH. All groups showed a similar faecal pH at baseline (~5 - 5.5) which 
significantly increased up to ~6-6.5 three weeks later (p < 0.05) (Fig. 3A). The C10 and REF 
groups had a similar faecal pH pattern until day 14, after that C10 diet reduced it (p = 0.035). CF 
and I diets resulted in a significant lower increase in the faecal pH from day 7 of diet in comparison 
to the REF (p = 0.015 and 0.002) and C10 groups (p = 0.001 and 0.0003). Significance remained 
until the end of the study with respect to the REF group (p = 0.009 in both cases). The reduction 
produced in the first two weeks by the I diet was stronger than that produced by the CF diet (day 
14; p = 0.001). Similarly to faecal pH, at the end of the study, the caecal pH was significantly 
reduced by C10, CF and I diets when compared to the REF group (p = 0.020, 0.004 and < 0.0001, 
respectively) (Fig. 3B). 
Fig. 3 Effects of cocoa fibre on faecal (A) and caecal pH (B) after three weeks of nutritional 
intervention. Results are expressed as mean ± SEM (n = 10). Reference diet (REF); Cocoa diet 
(C10); Cocoa fibre diet (CF); Inulin diet (I). Statistical differences: *p < 0.05 vs REF; α p < 0.05 vs 
C10; β p < 0.05 vs CF, δ p < 0.05 vs I and Φ p < 0.05 vs initial values. 
 
 
 
 
 
 
 
 
 
 3.4. Microbiota characterization by FCM-FISH. After three weeks of nutritional intervention, there 
were significant differences in the gut microbiota composition between groups (Table 3).  
Although the total counts of bacteria were not affected by the diets, the C10-fed animals had lower 
counts of Bifidobacterium, Staphylococcus and Streptococcus groups and higher of Bacteroides and 
Clostridium coccoides/Eubacterium rectale in comparison to the REF group (p < 0.05 in all cases). 
Similar effects on Bacteroides spp. were observed in the CF and I groups compared to the REF 
group (p = 0.021 and 0.05, respectively). However, both groups fed with different types of fibre 
without polyphenols (CF and I) resulted in a different gut microbiota composition compared to the 
REF diet for other genera. Whereas the C10 diet did not modify Lactobacillus group counts, CF and 
I diets enhanced its counts, being higher than that observed in REF group (p = 0.037 and 0.001, 
respectively). This enhancement was stronger in the I group than in the cocoa fibre-fed animals 
(p = 0.005). In contrast to the effects on Bifidobacterium spp. in animals fed the C10 diet, both fibre 
diets significantly enhanced their presence in the intestinal microbiota, in comparison with the REF 
group (p < 0.05 in all cases). Similarly, both diets based on fibre led to higher counts of 
Staphylococcus and Streptococcus groups than the C10 diet (p < 0.05 in all cases), with only the 
number of Streptococcus after CF intake being statistically higher than that in REF animals 
(p = 0.021). Clostridium histolitycum/C. perfringens counts in the CF and I groups were also higher 
than those in the REF group (p = 0.025 and 0.005, respectively), also being this increase observed 
in I-fed animals superior than those observed in the C10 group (p  = 0.034). Finally, faecal samples 
from the I group had also higher numbers of Clostridium coccoides/Eubacterium rectale groups 
compared to the REF group (p = 0.016). 
There was an inverse correlation between the faecal pH and the number of Clostridium 
histolyticum/C. perfringens and Bacteroides genera at the end of the study (r = -0.38, p = 0.03 and 
r = -0.37, p = 0.03; respectively). Moreover, the C10 decreased the Firmicutes to Bacteroidetes 
ratio, and as a result was significantly different from the REF diet (p = 0.025), CF (p = 0.049) and I 
groups (p = 0.023). 
 
 
 
  
  
After intervention 
Groups 
  
REF C10 CF I 
   
Mean  
(x10
7
 cells/g) 
SEM 
Mean  
(x10
7
 cells/g) 
SEM 
Mean  
(x10
7
 cells/g) 
SEM 
Mean  
(x10
7
 cells/g) 
SEM 
Total Bacteria 143.43 46.30 146.71 33.25 193.06 26.94 210.78 22.62 
Bacteroides (B) 3.46 1.14 7.45* 1.40 7.85* 1.63 7.36* 1.64 
Bifidobacterium (A) 3.71 0.71 1.68* 0.33 10.90*
α
 2.69 16.54*
α
 5.09 
Lactobacillus (F) 4.21 0.94 7.25 2.65 12.20* 2.77 24.38*
αβ
 4.23 
E. coli (P) 2.51 1.10 1.57 0.69 2.49 0.62 2.90 0.61 
Staphylococcus (F) 5.44 1.74 2.22* 0.61 12.26
α
 3.68 4.99
α
 1.06 
Streptococcus (F) 5.94 1.83 1.27* 0.21 18.30*
α
 5.20 6.55
α
 0.74 
Clostridium histolitycum/ 
C. perfringens (F) 3.40 1.22 6.53 1.69 11.69* 2.94 12.40*
α
 2.24 
Clostridium coccoides/ 
Eubacterium rectale (F) 3.41 1.11 9.99* 3.64 9.90 2.61 8.92* 1.39 
 
   
Mean  SEM Mean  SEM Mean  SEM Mean  SEM 
F/B ratio 
 
7.94 
 
1.29 
 
3.15* 
 
0.67 
 
8.06
 α
 
 
1.83 
 
9.11
 α
 
 
2.82 
 
Table 3 Bacterial counts of each genus relative to total bacteria determined by FISH-FCM in 
faeces. Microbiota composition data are expressed as the mean ± SEM of bacterial cells x10
7
/g of 
faeces. Firmicutes to Bacteroidetes ratio is expressed for each experimental group as the 
mean ± SEM. A: Actinobacteria; B: Bacteroidetes; F: Firmicutes; P: Proteobacteria. Reference 
diet (REF); Cocoa diet (C10); Cocoa fibre diet (CF); Inulin diet (I). Statistical differences: 
*p < 0.05 vs REF; α p < 0.05 vs C10; β p < 0.05 vs CF. 
 
 
 
 
 
 
 
 
3.5. IgA-coated bacteria. The proportion of faecal IgA-coated bacteria after the nutritional 
intervention was ~10 % lower in the C10 group compared to the REF group (p = 0.007) (Fig. 4). In 
contrast, the CF and I diets led to a significantly higher proportion of IgA-coated bacteria in 
comparison with the REF and C10 diets (p < 0.02 in all cases).  
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Fig. 4 Effects of cocoa fibre on percentage of 
faecal bacteria coated with IgA after 3 weeks of 
nutritional intervention. Results are expressed as 
mean percentage ± SEM (n = 10). Reference 
diet (REF); Cocoa diet (C10); Cocoa fibre diet 
(CF); Inulin diet (I).  Statistical differences: *p < 
0.05 vs REF; α p < 0.05 vs C10. 
 
 Fig. 5
Tlr2 Tlr4 Tlr5 Tlr7 Tlr9 Ocldn
P
er
ce
n
ta
g
e 
(%
)
0
100
200
300
400
500
2000
4000
6000
8000
REF 
C10 
CF 
I 
*α
*
*α
* α
*
*
*
*
δ
δ
δ
δ
REF C10 CF I
When samples from all groups were considered together, the proportion of IgA-coated bacteria 
positively correlated with the numbers of Lactobacillus, Bifidobacterium and Streptococcus genera 
at the end of the study (r = 0.44, p = 0.01 for Lactobacillus; r = 0.35, p = 0.04 for Bifidobacterium 
and r = 0.41, p = 0.02 for Streptococcus). 
3.6. Colonic TLR gene expression. Gene expression of TLR2, TLR4, TLR5, TLR7, TLR9 and 
occludin was assessed in the colon tissue at the end of the study (Fig. 5). The C10 diet did not 
modify TLR gene expression, but it induced a significant twofold increase in occludin mRNA 
levels in comparison with the REF group (p = 0.008). Colonic TLR4 and TLR9 gene expression 
was not modified in the CF-fed animals, whereas TLR2, TLR5, TLR7 and occludin expressions 
were ~ fiftyfold, twentyfold, thirty-fivefold and threefold up-regulated compared to the REF group, 
respectively (p < 0.0000, p = 0.002, 0.001 and 0.008, respectively). These significant increases in 
TLR2, TLR7 and occludin expression were also observed in the inulin-fed animals, but were more 
modest (p = 0.016, 0.004 and 0.041, respectively). 
Fig. 5 TLR gene expressions in the colon after nutritional intervention with cocoa fibre diet. 
Expression values are normalized using the expression of Gusb as the endogenous housekeeping 
gene. Each bar represents the mean ± SEM of the percentage of the C10 group (white bars), CF 
group (grey bars) and I group (striped bars) with respect to the REF group (black bars), which 
represents 100% gene expression. Reference diet (REF); Cocoa diet (C10); Cocoa fibre diet (CF); 
Inulin diet (I). Significant differences: *p < 0.05 vs REF; α p < 0.05 vs C10; and δ p < 0.05 vs I. 
 
 
 
 
 
 
 
 
 4. Discussion 
After ingestion of cocoa, both its polymeric flavonoids and fibre reach the colon intact, where 
commensal bacteria have an opportunity to metabolize them (Monagas et al. 2010; Selma et al. 
2009) and the resulting metabolites can influence the intestinal environment and the immune 
system. Here we demonstrate that fibre from cocoa, consumed by rats for three weeks, exerts 
stronger prebiotic effects than inulin by increasing Bifidobacterium and Lactobacillus genera, 
SCFA production, and the gene expression of microbial receptors and tight junction molecules 
while decreasing both caecal and faecal pH. 
It is well known that non-digestible complex carbohydrates are metabolized by the microbiota to 
oligosaccharides and then fermented to SCFA (Puertollano et al. 2014), but fermentation of fibre 
from cocoa has not been investigated. In the current study, consumption of cocoa fibre led to the 
profound changes in SCFA production both in faeces and caecum, which were greater than the 
effects of the well-characterized prebiotic, inulin, but this did not occur after cocoa consumption. 
Cocoa fibre resulted in higher production of all three of the main SCFA (acetic, propionic and 
butyric acids) in caecum content, which play an important role in host health (Puertollano et al. 
2014; Tan et al. 2014). Nevertheless, the intake of whole cocoa, containing the same proportion of 
fibre as CF diet, but also the other components present in cocoa, such as flavonoids, did not result in 
significant changes in all three of the main SCFA, with the exception of a higher butyric acid 
concentration in the caecum. This suggests that phenolics and other compounds in cocoa may 
inhibit colonic fibre metabolism. This lack of effect of cocoa could contribute to the lower energy 
harvest and therefore the lower weight gain observed in animals fed with C10 diet both in the 
current and in previous studies (Massot-Cladera et al. 2013; Massot-Cladera et al. 2012; Pérez-
Berezo et al. 2009; Ramiro-Puig et al. 2007; 2008). Inulin diet did not modify the production of so 
many SCFA as CF diet did in the current study. However, inulin is a well-known prebiotic 
extensively metabolized which leads to significant SCFA production (Meyer & Stasse-Wolthuis, 
2009; Roberfroid, 2002). These distinguishing results  related to the inulin could be attributed to 
several factors such as the methodologies, population groups, length of intervention as well as the 
type and dose of inulin used (Kolida et al. 2007). Our results show that cocoa fibre diet has been 
more metabolized than the inulin one and, therefore higher energy harvest and functional benefits 
from those generated SCFA. 
In order to classify a food ingredient as a prebiotic not only must it be selectively fermented, but it 
must also be able to alter the colonic microflora towards a healthier composition (Kolida et al. 
 2002). In the present study, concurrently with changes in the intestinal SCFA production described 
above, the CF modified the faecal microbiota composition. Specifically, the CF diet resulted in a 
significantly higher proportion of acetic acid-producing bacteria such as Bifidobacterium and 
Lactobacillus, similarly to what happened in I group. The growth of both genera after prebiotic 
ingestion is commonly related to positive benefits on health. Whole cocoa did not increase 
Bifidobacterium counts, suggesting that, as with SCFA production, other compounds present in 
cocoa could be suppressing the prebiotic effect exerted by its fibre. The major fraction of cocoa 
fibre is insoluble and rich in cellulose, followed by highly fermented pectic substances and 
hemicellulose, which is less fermentable than the former (Lecumberri et al. 2007) and contains a 
lesser amount of other cocoa compounds (i.e. polyphenols) (Cullen & Oace, 1989). In addition,  
polyphenols have been also described to possess antimicrobial effects (Lee et al. 2006; Puupponen-
Pimiä et al. 2005). Overall, cocoa fibre composition lacking polyphenols allows promoting the 
growth of beneficial bacteria.  
Regarding cocoa polyphenols, controversial results have been reported concerning their capacity to 
enhance the growth of beneficial bacteria in in vitro, in vivo and clinical studies (Etxeberria et al. 
2013; Fogliano et al. 2011; Massot-Cladera et al. 2014; Tzounis et al. 2008). Some studies suggest 
that cocoa flavanols promote the growth of Bifidobacterium, Lactobacillus and Eubacterium 
rectale–C. coccoides genera (Tzounis et al. 2008; 2011). However, we have previously reported a 
decrease in the proportion of these using different types of cocoa polyphenol extracts (Massot-
Cladera et al. 2014). Moreover, cocoa polyphenols have been associated with an inhibitory effect on 
the growth of C. histolyticum/C. perfringens, Bacteroides, Staphylococcus and Streptococcus 
genera in in vitro, preclinical and clinical studies (Massot-Cladera et al. 2012; 2014; Tzounis et al. 
2008; 2011). These differential results could be attributed to several factors such as cocoa 
composition (i.e. polyphenols, fibre, methylxanthines), dose and dissimilar composition and 
distribution intestinal ecosystem (rats vs human gut).  
The enhancement of the growth of beneficial bacteria produced by both fibre diets could be 
partially due to and/or caused by their effects on faecal pH. The faecal content acidification, which 
is closely related to the concentration of SCFA, could be the consequence of the prebiotic effects of 
fibre, promoting the growth of specific SCFA-producing bacteria, which are able to resist in this 
environment. These conditions suppress at the same time the growth of certain opportunistic 
bacteria. C10 diet also produced more acidic faeces than those from reference group, but less acidic 
than those observed in CF group. The faecal pH reduction by the C10 diet did not appear to be 
 associated with the SCFA concentration. Thus, the prebiotic effects of CF showed here may be 
hindered by other cocoa compounds such as polyphenols or methylxanthines which could reduce 
the pH through different mechanisms. Further studies should be carried out in order to evaluate the 
effects of the main methylxanthine present in cocoa (theobromine) on microbiota, SCFA and pH are 
recommended. 
The C10 diet significantly decreased the proportion of IgA-coated bacteria, which is consistent with 
previous data ( Massot-Cladera et al. 2012; 2014). In contrast, the CF and inulin diets increased the 
proportion of IgA-coated bacteria, once again suggesting that non-fibre components of cocoa 
counteract the effects of the cocoa fibre. Moreover, the proportion of IgA-coated bacteria was 
associated with the number of faecal Lactobacillus, Bifidobacterium and Streptococcus genera. 
These results may suggest that the changes in these bacteria genera influence the differentiation of 
IgA
+
 B cells and/or IgA synthesis in the intestinal compartment, processes in which TLR 
transduction signals are involved.  
For this reason, the gene expression of selected TLRs and molecules involved in intestinal barrier 
function, and therefore in the paracellular crossing of antigens through epithelial barrier, such as 
occludin, were also examined in colon specimens. There was greater expression of TLR2, TLR5, 
TLR7 and occludin in the CF-fed animals than in REF animals, whereas the C10 diet tended to 
increase the expression of TLR4 and reduce that of TLR9, in agreement with previous studies using 
a 10% cocoa diet with similar experimental design (Massot-Cladera et al. 2012). Both TLRs and 
occludin have been positively associated with the appropriate functionality of the intestinal 
compartment. The principal role of TLRs is defense against opportunistic bacteria by means of 
promoting signals for IgA and antimicrobial peptide expression, barrier fortification and 
proliferation of epithelial cells after the bacterial molecules (Abreu et al. 2005; 2010). In particular, 
TLR2 recognizes a wide variety of molecules (peptidoglycan, lipopeptides and lipoproteins of 
Gram-negative bacteria, mycoplasma lipopeptides and fungal zymosan); TLR4 interacts with 
bacterial lipopolysaccharide; TLR5 recognizes bacterial flagellin; nucleic acids are essential to 
activate TLR7 whereas TLR9 recognizes motifs commonly present in bacterial and viral genomes 
(Pérez-Cano et al. 2014). On the other hand, occludin together with the large family of claudins and 
tight junction adhesion molecules, have been reported to be essential for the correct morphology 
and functionality of the epithelial barrier (Wang et al. 2013). Therefore, it is plausible that the 
preventive effect of cocoa and/or cocoa fibre on certain intestinal chronic/inflammatory diseases 
may at least in part result from effects on TLRs and occludin. The present results suggest that, with 
 the exception of occludin, cocoa fibre is chiefly responsible for this modulation, which may reflect 
the changes in the intestinal microbiota and/or its direct relationship with intestinal epithelial and 
immune cells.  
Although there was no difference in food intake between dietary groups, animals in the C10 group 
showed lower body weight gain, in agreement with previous studies (Massot-Cladera et al. 2012; 
2013; Pérez-Berezo et al. 2009; Ramiro-Puig et al. 2007). The ability of flavonoids to inhibit lipid 
digestion and absorption (Gu et al. 2011), to reduce fat deposition ; Min et al., 2013; Cherniack, 
2011; Faisal et al. 2015) and/or to down-regulate the expression of genes involved in lipid 
metabolism (unpublished own data from current analysis) are proposed mechanisms by which 
cocoa intake may affect body weight gain. Another possible mechanism is the effects of 
polyphenols on the gut microbiota composition. A number of studies have addressed the association 
between the ratio of the two main phyla (Firmicutes and Bacteroidetes) and obesity or weight loss 
(Sanz et al. 2013). Specifically, it has been reported that Bacteroidetes possess fewer genes for 
enzymes involved in lipid and carbohydrates metabolism than Firmicutes (Jumpertz et al. 2011; 
Kallus & Brandt, 2012). Therefore, the lower body weight gain in the C10 group could be partially 
attributed to both the lower counts of Staphylococcus and Streptococcus (belonging to the 
Firmicutes phylum) and the increase in Bacteroides (included in Bacteroidetes phylum) leading to a 
lesser ratio of Firmicutes to Bacteroidetes. Neither this lower F/B ratio nor a lower body weight 
increase was observed in animals fed the CF diet, which suggests that other cocoa compounds must 
be involved in such regulation. A previous study including the intake of diets containing high 
proportions of cocoa polyphenols (Massot-Cladera et al. 2014) also reported no effects on body 
weight. Therefore, methylxanthines present in cocoa may be involved, as suggested by Dulloo 
(Dulloo, 2011), who demonstrated a synergistic thermogenic interaction between methylxanthines 
and flavonoids (Dulloo, 2011).  
 
5. Conclusions 
Although previous studies showed that the intake of whole cocoa modulates the intestinal 
compartment, the results from the present study shed light on the contribution of cocoa fibre to 
these effects. In particular, fibre contained in cocoa modulates the microbiota composition, 
enhancing the growth of beneficial bacteria (Lactobacillus and Bifidobacterium genera) that are 
associated with a beneficial SCFA profile and, as a result, with a lower caecal and faecal pH. The 
 CF also reinforces intestinal immune defenses and barrier function by means of IgA-CB and 
occludin enhancement. Fibre from cocoa therefore possesses prebiotic properties. In addition, cocoa 
fibre in the colon modulated the expression of some TLR genes. Since whole cocoa did not 
replicate the effects of the CF, it is likely that other cocoa compounds mask the effects of its fibre.  
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